Cite
MLA Citation
A. Cahn et al.. “Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD.” Pulmonary pharmacology & therapeutics, vol. 46, n.d., pp. 69–77. http://access.bl.uk/ark:/81055/vdc_100066564023.0x000023